PFE Past Earnings Q&A
What was the best and worst PFE past earnings results?
For Pfizer, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?
The highest PFE past earnings result in our data set was 2.040/share posted in Q2 2022, while the lowest was in Q1 2012 when PFE posted 0.24/share.
The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when PFE reported 27.74B in revenue, while the quarter with the lowest revenue in our data set was Q1 2015 at 10.86B of revenue.
There are 44 PFE past earnings results in our data set.
On this page we presented the PFE past earnings date information for Pfizer. Reviewing that
PFE Past Earnings
for the company, we see that the highest past earnings result in our data set was in Q2 2022, when PFE posted adjusted EPS of 2.040/share. Meanwhile the lowest PFE past earnings result was in Q1 2012, when PFE posted adjusted EPS of 0.24/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when PFE reported 27.74B in revenue, while the smallest revenue quarter was Q1 2015 when PFE reported 10.86B in revenue.
Any self directed investor doing their due diligence on PFE or any other given stock can benefit from
researching all of the Pfizer past earnings — and here, we present each quarter's result all together
on one page for easy comparison. Studying this information can help when projecting future earnings, as well
as determining whether the past earnings trajectory justifies the current stock value.
That's why we bring you PastEarnings
.com to make it easy for investors to investigate
Pfizer past earnings, or the past earnings information for any stock in our coverage universe.
And in your continued research we hope you will be sure to check out the further links included for earnings
surprises history (beat/miss data) as well as next earnings dates for PFE. Thanks for visiting, and the next
time you need to research PFE past earnings
or those of another stock, we hope you'll think of our site, as your
go-to past earnings research resource of choice.